Sufentanil Injection Shortage
Last Updated: January 22, 2021
Status: Resolved
Reason for the Shortage
-
- Akorn had Sufenta injection on shortage due to increased demand for the product.
- Hikma stopped marketing sufentanil injection in October 2018.
- Pfizer had sufentanil injection on shortage due to manufacturing delays.
Available Products
-
- Sufenta solution for injection, Akorn, 50 mcg/mL, 1 mL ampule, 10 count, NDC 17478-0050-01
- Sufenta solution for injection, Akorn, 50 mcg/mL, 2 mL ampule, 10 count, NDC 17478-0050-02
- Sufenta solution for injection, Akorn, 50 mcg/mL, 5 mL ampule, 10 count, NDC 17478-0050-05
- Sufentanil solution for injection, Pfizer, 50 mcg/mL, 1 mL vial, 10 count, NDC 00409-3382-21
- Sufentanil solution for injection, Pfizer, 50 mcg/mL, 2 mL vial, 10 count, NDC 00409-3382-22
- Sufentanil solution for injection, Pfizer, 50 mcg/mL, 5 mL vial, 10 count, NDC 00409-3382-25
Estimated Resupply Dates
-
- All marketed presentations are available.
Implications for Patient Care
-
- ASHP has an FAQ on the injectable opioid shortage at https://www.ashp.org/Drug-Shortages/Shortage-Resources/Injectable-Opioid-Shortages-FAQ. This discusses multiple issues including inventory and pharmacy operational strategies.
Updated
Updated January 22, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 12, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.